Drug & supplement interaction

Beta-cryptoxanthin + Nivolumab

Nivolumab brand name: Opdivo.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Beta-cryptoxanthin and Nivolumab in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the label for Nivolumab states a food rule worth keeping to.

Know someone taking this? Share
Interaction report

Beta-cryptoxanthin and Nivolumab

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Nivolumab and Beta-cryptoxanthin in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Worth understanding: our licensed dataset holds no drug-interaction record for Beta-cryptoxanthin at all — not against Nivolumab, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Beta-cryptoxanthin safety at a glance

Beta-cryptoxanthin overall Use caution Considered safe in normal food amounts, but the safety of high-dose supplements is not well studied.
Pregnancy Likely Safe When used orally and appropriately in amounts found in foods. There is insufficient reliable information available about the safety of supplemental beta-cryptox... Read the full pregnancy detail
Breastfeeding Likely Safe When used orally and appropriately in amounts found in foods. There is insufficient reliable information available about the safety of supplemental beta-cryptox... Read the full breastfeeding detail

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center) — the full detail is in the Special populations card below. Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Nivolumab and Beta-cryptoxanthin? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
What to actually watch for

What Nivolumab’s Own FDA Label Lists

This is not an interaction — none of it involves Beta-cryptoxanthin. These are the most notable effects listed in the ADVERSE REACTIONS section of Nivolumab’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 10 of them are worth acting on rather than waiting out — marked below.

  • Low magnesium Worth acting on
  • A change in thyroid levels Worth acting on
  • A stroke or mini-stroke Worth acting on
  • Severe muscle breakdown Worth acting on
  • Dehydration Worth acting on
  • Trouble swallowing Worth acting on
  • Bleeding in the gut Worth acting on
  • High potassium Worth acting on
  • Low sodium Worth acting on
  • Low blood sugar Worth acting on

Showing the 10 most notable of 67 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Nivolumab. Read the label on DailyMed › Where a percentage is shown, it is the share of 96,645 voluntary FDA FAERS reports for Nivolumab that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Beta-cryptoxanthin’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Beta-cryptoxanthin side to compare — that is a limit of the record, not a statement that Beta-cryptoxanthin has no side effects.

Special populations

Beta-cryptoxanthin in Pregnancy & Breastfeeding

Pregnancy And Lactation Likely Safe

When used orally and appropriately in amounts found in foods. There is insufficient reliable information available about the safety of supplemental beta-cryptoxanthin; avoid use.

DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center

How to take them

Some Nivolumab Products Have a Food Rule — Beta-cryptoxanthin Should Not Break It

At least one FDA label for a product containing Nivolumab says to take it on an empty stomach. Most supplements — Beta-cryptoxanthin included — are taken with a meal, so the easy mistake is swallowing both together at breakfast. Where that rule applies, keep Nivolumab on its own and move Beta-cryptoxanthin to a meal later in the day.

This may not be true of your version. Food instructions belong to the product, not the ingredient: two Nivolumab products can carry different directions, and extended-release forms often differ from immediate-release ones. The label we read is quoted below — check the directions on your own box or bottle, or ask your pharmacist, for how to take the exact product you were given.

Table 2: Recommended Dosages of Intravenous OPDIVO in Combination with Other Therapeutic Agents Indication Recommended OPDIVO Dosage Duration of Therapy Unresectable or metastatic melanoma 1 mg/kg every 3 weeks with ipilimumab 3 mg/kg In combination with ipilimumab for a maximum of 4 doses or until unacceptable toxicity, whichever occurs earlier Adult patients and pediatric patients aged 12 years

From the Dosage and Administration section of the FDA label we read for Nivolumab — where that label names a specific product, the instruction is that product's. Read the label on DailyMed ›

A food rule is not an interaction — it is about how much of the medicine you absorb. The directions that came with your own product, and your pharmacist, outrank anything on this page.

Overlapping uses

What Nivolumab Is Prescribed For, and What Beta-cryptoxanthin Has Been Studied For

These two come up together because they touch the same health topic — not because they do the same job. Nivolumab is a prescription medicine with approved uses on its FDA label. Beta-cryptoxanthin is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.

Nivolumab is prescribed for: Opdivo (nivolumab) is used to treat many types of cancer in adults, and some in patients 12 years and older. It can be used alone or in combination with other therapies depending on the cancer type and stage. Cancers it treats include melanoma (including after surgery to reduce the chance of the cancer coming back), non-small cell lung cancer, malignant pleural mesothelioma, advanced renal cell carcinoma (kidney cancer), classical Hodgkin lymphoma, squamous cell carcinoma of the head and neck, urothelial carcinoma (bladder cancer), colorectal cancer with specific genetic features (MSI-H or dMMR), hepatocellular carcinoma (liver cancer), esophageal cancer, gastroesophageal junction cancer, and gastric (stomach) cancer. Some uses require the tumor to test positive for a protein called PD-L1, and some are specific to certain stages of disease or prior treatments received.

Read the rest of what Nivolumab is prescribed for

Your oncologist will determine which use applies to your situation.

Beta-cryptoxanthin has been studied for:

  • Lung cancer studied, not established Beta-cryptoxanthin has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows

    Beta-cryptoxanthin for lung cancer

    It is unclear if dietary beta-cryptoxanthin intake can reduce the risk of lung cancer.

  • Head and neck cancer studied, not established Beta-cryptoxanthin has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows

    Beta-cryptoxanthin for head and neck cancer

    Although there has been interest in using oral beta-cryptoxanthin for head and neck cancer prevention, there is insufficient reliable information about the clinical effects of beta-cryptoxanthin for this purpose.

  • Gastric cancer studied, not established Beta-cryptoxanthin has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows

    Beta-cryptoxanthin for gastric cancer

    It is unclear if dietary beta-cryptoxanthin intake can reduce the risk of gastric cancer.

Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Nivolumab on your own; if you are taking Beta-cryptoxanthin for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.

Everything else you take

See Every Supplement That Interacts With Nivolumab

This page covers Beta-cryptoxanthin only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Nivolumab page lists 1 supplement it has a documented interaction with, worst first, each one explained.

The most serious there right now: American Pawpaw (minor).

By severity: 1 minor.

From our pharmacist’s overview on the Nivolumab page

“Nivolumab (Opdivo) is an immunotherapy infusion that trains the body's own immune system to recognize and attack cancer cells, the kind of drug you might expect to carry a long list of supplement warnings. It does not.”

Reviewed by 2 · Jul 18, 2026

Open the Nivolumab interaction page

How much people look this up

Where Beta-cryptoxanthin and Nivolumab Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Beta-cryptoxanthin
Steady interest

#1,265 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Nivolumab
Top 25%

#558 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions. Beta-cryptoxanthin is not yet covered by that licensed database, so its write-up cites publicly available medical sources directly (see the references below).
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Beta-cryptoxanthin reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Beta-cryptoxanthin and Nivolumab records this page draws on were last updated July 11, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Beta-cryptoxanthin

What is Beta-cryptoxanthin?

  • Antioxidant support
  • Eye health
  • Bone health
  • Vitamin A source
  • General wellness

Beta-cryptoxanthin is a natural orange-red plant pigment (a carotenoid) found in fruits like oranges, tangerines, and papaya, and it can be turned into vitamin A in the body. Diets rich in beta-cryptoxanthin are linked in some studies to better bone and lung health, but the evidence for supplements is limited. For most people, getting it from colorful fruits and vegetables is the safest and best-studied approach.

Naturally found in fruits and vegetables; also made as a supplement · Capsules, softgels, and multivitamin/carotenoid blends; naturally present in whole foods

An interaction check asks whether these two react with each other — it does not ask whether Beta-cryptoxanthin is a good idea for someone in your situation. Here is what our Beta-cryptoxanthin record says about it on its own.

Beta-cryptoxanthin: dosing

There is no established standard supplement dose for beta-cryptoxanthin. Most research reflects amounts obtained through a normal diet rich in fruits and vegetables rather than from pills.If you choose to take a supplement, follow the directions on the product label and do not exceed the recommended amount.

From our Beta-cryptoxanthin monograph — the full record covers uses, side effects and every documented interaction.

Read the full Beta-cryptoxanthin monograph & all interactions
Medication

About Nivolumab Injection

What Is Nivolumab Injection Used For?

Brand name: Opdivo

Opdivo (nivolumab) is used to treat many types of cancer in adults, and some in patients 12 years and older. It can be used alone or in combination with other therapies depending on the cancer type and stage. Cancers it treats include melanoma (including after surgery to reduce the chance of the cancer coming back), non-small cell lung cancer, malignant pleural mesothelioma, advanced renal cell carcinoma (kidney cancer), classical Hodgkin lymphoma, squamous cell carcinoma of the head and neck, urothelial carcinoma (bladder cancer), colorectal cancer with specific genetic features (MSI-H or dMMR), hepatocellular carcinoma (liver cancer), esophageal cancer, gastroesophageal junction cancer, and gastric (stomach) cancer.

Some uses require the tumor to test positive for a protein called PD-L1, and some are specific to certain stages of disease or prior treatments received. Your oncologist will determine which use applies to your situation.

Most-Reported Side Effects for Nivolumab

From FAERS, the FDA’s public side-effect reporting system (96,645 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Malignant neoplasm progression 9,878 reports
Diarrhea 5,251 reports
Fatigue 4,195 reports
Fever 3,721 reports
Nausea 3,182 reports
See full Nivolumab Injection drug information
Keep checking

Other Drugs & Beta-cryptoxanthin

Browse every other medication we’ve checked against Beta-cryptoxanthin — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No interaction 2,829 drugs checked — show the list
Evidence & sources

Beta-cryptoxanthin References

The 2 sources that drive our Beta-cryptoxanthin monograph — publicly available pages from reputable medical and government organizations. Every link was verified to work before publishing. Beta-cryptoxanthin is not covered by the licensed Natural Medicines interaction database, so its page cites these public sources directly.

  1. Vitamin A and Carotenoids - Health Professional Fact Sheet — NIH Office of Dietary Supplements Source
  2. Vitamin A — MedlinePlus Source

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Beta-cryptoxanthin and Nivolumab Together: Common Questions

Is it safe to take Beta-cryptoxanthin with Nivolumab?
We do not list a known interaction between Beta-cryptoxanthin and Nivolumab. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Should I take Beta-cryptoxanthin and Nivolumab at the same time of day?
At least one FDA label for a product containing Nivolumab says to take it on an empty stomach, and supplements are usually taken with a meal — so taking them together at breakfast is the easy mistake. Where that applies, keep Nivolumab on its own and move Beta-cryptoxanthin to a meal later in the day. Food instructions belong to the product rather than the ingredient, so check the directions on your own box. This is about absorption, not an interaction.
Are Beta-cryptoxanthin and Nivolumab used for the same thing?
They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for Beta-cryptoxanthin in each. That is a conversation for your prescriber, especially if Nivolumab is being adjusted to a target.
Does Nivolumab interact with any supplements?
Yes. Nivolumab has documented interactions with 1 supplement in our database — Beta-cryptoxanthin is not one of them. The Nivolumab interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Nivolumab and Beta-cryptoxanthin?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.